LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 363 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $255,000 | -36.6% | 3,505 | -9.0% | 0.03% | -17.5% |
Q4 2019 | $402,000 | +5.0% | 3,850 | 0.0% | 0.04% | -4.8% |
Q3 2019 | $383,000 | -15.1% | 3,850 | -2.5% | 0.04% | -14.3% |
Q2 2019 | $451,000 | -10.2% | 3,950 | -1.1% | 0.05% | -10.9% |
Q1 2019 | $502,000 | -6.7% | 3,995 | +0.8% | 0.06% | -16.7% |
Q4 2018 | $538,000 | -45.7% | 3,965 | +9.8% | 0.07% | -36.5% |
Q3 2018 | $991,000 | +32.5% | 3,610 | 0.0% | 0.10% | +22.4% |
Q2 2018 | $748,000 | +23.4% | 3,610 | -1.6% | 0.08% | +19.7% |
Q1 2018 | $606,000 | +20.7% | 3,667 | 0.0% | 0.07% | +26.8% |
Q4 2017 | $502,000 | +0.6% | 3,667 | 0.0% | 0.06% | -5.1% |
Q3 2017 | $499,000 | +12.1% | 3,667 | 0.0% | 0.06% | +9.3% |
Q2 2017 | $445,000 | +14.7% | 3,667 | 0.0% | 0.05% | +10.2% |
Q1 2017 | $388,000 | -20.3% | 3,667 | -23.5% | 0.05% | -24.6% |
Q4 2016 | $487,000 | -3.0% | 4,792 | -2.5% | 0.06% | -4.4% |
Q3 2016 | $502,000 | +128.2% | 4,917 | +166.5% | 0.07% | +126.7% |
Q2 2016 | $220,000 | – | 1,845 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $6,891 | 2.63% |
VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |